Skip to content Skip to navigation

Can ‘Big Data’ Help Increase Drug Safety?

October 9, 2013
by John DeGaspari
| Reprints
Researchers use an EHR database to reduce adverse effects

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report that by adding a second drug to the diabetes drug rosiglitazone, adverse events dropped enormously. That suggests that drugs could be repurposed to improve drug safety, including lowering the risk of heart attacks. The research is published online Oct. 9 in the journal Science Translational Medicine.

 “Big data systems have a wealth of data, and when studied appropriately, can point to potentially safer combinations,” said Ravi Iyengar Ph.D., professor of pharmacology and director of the Systems Biology Center at the Icahn School of Medicine at Mount Sinai. He said that findings from big data analyses, although preliminary, can point to potentially safer combinations that can subsequently be tested in clinical trial. “We may be able to use FDA-approved drugs to prevent adverse events,” he said

In this study, investigators studied how drug combinations act through networks within cells, focusing on the diabetes drug rosiglitazone, an effective drug in controlling blood glucose. However, rosiglitazone has a serious side effect, increased heart attacks, which have restricted its use markedly. Investigators analyzed data from the FDAERS to see if second drugs could lower the rate heart attacks, and compared their results with Mount Sinai's electronic health records system. They found that the drug exanatide, often given along with rosiglitazone to get better control of blood glucose, also very substantially reduced the heart attack rate in rosiglitazone users. Iyengar’s team also found nearly 19,000 other drug combinations in the FDA database, where the second drug appears to reduce a wide range of side effects of the first drug.

The research team said that that the results are a valid starting point for developing clinical trials of safer drug combinations, and urged researchers and clinicians to contribute to big databases, such as the FDA’s Adverse Event Reporting System.

 

Topics

News

Allegheny Health Network, VA Pittsburgh Integrate EMR Systems

Allegheny Health Network (AHN), based in Pittsburgh, and VA Pittsburgh Healthcare System (VAPHS), have announced the successful integration of their electronic medical record (EMR) platforms.

Wisconsin Urology Group Notifies Patients of Data Breach Due to Ransomware Attack

Wauwatosa, Wis.-based Metropolitan Urology Group has notified its patients of a breach of unsecured patient health information due to a ransomware attack back in November 2016.

Study: For Post-Op Patients, Mobile Apps for Follow-Up Care Led to Fewer In-Person Visits

For patients undergoing ambulatory surgery, those who used a mobile app for follow-up care attended fewer in-person visits post- operation than patients who did not use the app, according to a study in JAMA Surgery.

Information Blocking is Routine and Fairly Widespread, Survey of HIEs Finds

In a survey, 50 percent of HIE leaders said electronic health record (EHR) vendors "routinely" engage in information blocking, and 25 percent reported that hospitals and health systems routinely engage in business practices that interfere with electronic health information exchange.

ONC Updates SAFER Guides to Address EHR Safety

The Office of the National Coordinator for Health IT (ONC) published updated safety best practices, called the Safety Assurance Factors for Electronic Health Record Resilience (SAFER) Guides, to identify recommended practices to optimize the safety and safe use of electronic health records (EHRs).

Survey: Healthcare Organizations Remain Underprepared for MACRA

Two-thirds of healthcare providers report that they are “unprepared” or “very unprepared” for managing and executing Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) initiatives, according to a survey from Pittsburgh-based Stoltenberg Consulting Inc.